PCNA and non-small cell lung carcinoma: However, down‐regulation of miR‐338 significantly promoted NSCLC cells proliferation (Figure 3b), increased the expressions of PCNA, CDK4, cyclin D1 and decreased the expression of p27 in NSCLC cells (Figure 3c).